Researcher.Life Logo

Neurology and Therapy : Impact Factor & More

eISSN: 2193-6536pISSN: 2193-8253
JournalOpen Access

Key Metrics

CiteScore
5.3
Eigenfactor
0.001 - 0.005
H-Index
29
Impact Factor
< 5
SJR
Q2Neurology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurology and Therapy

Neurology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER LONDON LTD
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Neurology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurology and Therapy

Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.
  • 1 Jun 2026
  • Neurology and therapy
Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives.
  • 1 Jun 2026
  • Neurology and therapy
From Environment to Symptoms: Mapping Premorbid Risk Factors onto Clinical Features of ALS in a Patient-Reported Database in China.
  • 1 Jun 2026
  • Neurology and therapy
Efgartigimod in Patients with Generalized Myasthenia Gravis Refractory or Intolerant to IVIg.
  • 1 Jun 2026
  • Neurology and therapy
Initial Monotherapy and Further Anti-seizure Medication Regimens in Adult Patients with Epilepsy: A Population-Based, Longitudinal, Retrospective Analysis of German Prescription Data.
  • 1 Jun 2026
  • Neurology and therapy
Practical Guidance for Initiation and Management of Patients on Once-Nightly Sodium Oxybate for Narcolepsy Treatment: Modified Delphi Panel Consensus Recommendations.
  • 1 Jun 2026
  • Neurology and therapy
Natural History of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP): A Retrospective Patient Cohort Study.
  • 1 Jun 2026
  • Neurology and therapy
Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives.
  • 1 Jun 2026
  • Neurology and therapy
From Environment to Symptoms: Mapping Premorbid Risk Factors onto Clinical Features of ALS in a Patient-Reported Database in China.
  • 1 Jun 2026
  • Neurology and therapy
Efgartigimod in Patients with Generalized Myasthenia Gravis Refractory or Intolerant to IVIg.
  • 1 Jun 2026
  • Neurology and therapy
Initial Monotherapy and Further Anti-seizure Medication Regimens in Adult Patients with Epilepsy: A Population-Based, Longitudinal, Retrospective Analysis of German Prescription Data.
  • 1 Jun 2026
  • Neurology and therapy
Practical Guidance for Initiation and Management of Patients on Once-Nightly Sodium Oxybate for Narcolepsy Treatment: Modified Delphi Panel Consensus Recommendations.
  • 1 Jun 2026
  • Neurology and therapy

FAQs on Neurology and Therapy